Chinese Drug Companies Form Alliance To Make Generic Viagra

Law360, New York (August 5, 2004, 12:00 AM EDT) -- An alliance of 17 Chinese drug makers have set up a joint-stock company to produce an erectile dysfunction drug in the wake of Pfizer’s loss of patent protection for Viagra in China, according to the Beijing Morning Post.

The 17 companies met in Beijing last week to discuss issues regarding the establishment of the alliance, the newspaper reported.

Tonghua Hongtaomao Pharmaceutical and Chongqing Kangerwei Pharmaceutical are spearheading the group, which has decided to manufacture generic sildenafil, the active pharmaceutical ingredient in Viagra.

The newspaper said the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.